Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Joshua Blume, Luisa Claus, Tamara Isermann, Antje Dickmanns, Lena-Christin Conradi, Ramona Schulz-Heddergott & Matthias Dobbelstein. (2023) CDK4/6 inhibition confers protection of normal gut epithelia against gemcitabine and the active metabolite of irinotecan. Cell Cycle 22:13, pages 1563-1582.
Read now
Read now
Lin Wang, Xiao-Cong Pang, Zi-Ru Yu, Sheng-Qian Yang, Ai-Lin Liu, Jin-Hua Wang & Guan-Hua Du. (2017) Actinomycin D synergistically enhances the cytotoxicity of CDDP on KB cells by activating P53 via decreasing P53–MDM2 complex. Journal of Asian Natural Products Research 19:6, pages 630-643.
Read now
Read now
Sivan Pearl Mizrahi, Orit Gefen, Itamar Simon & Nathalie Q. Balaban. (2016) Persistence to anti-cancer treatments in the stationary to proliferating transition. Cell Cycle 15:24, pages 3442-3453.
Read now
Read now
Chit Fang Cheok. (2012) Protecting normal cells from the cytotoxicity of chemotherapy. Cell Cycle 11:12, pages 2227-2227.
Read now
Read now
Dominique Kranz & Matthias Dobbelstein. (2012) A killer promoting survival: p53 as a selective means to avoid side effects of chemotherapy. Cell Cycle 11:11, pages 2053-2054.
Read now
Read now
Articles from other publishers (42)
Hong Yang, Sha Li, Wan Li, Yihui Yang, Yizhi Zhang, Sen Zhang, Yue Hao, Wanxin Cao, Fang Xu, Hongquan Wang, Guanhua Du & Jinhua Wang. (2023) Actinomycin D synergizes with Doxorubicin in triple-negative breast cancer by inducing P53-dependent cell apoptosis. Carcinogenesis.
Crossref
Crossref
Mikhail V. Blagosklonny. (2023) Selective protection of normal cells from chemotherapy, while killing drug-resistant cancer cells. Oncotarget 14:1, pages 193-206.
Crossref
Crossref
Maha A. Fahmy, Entesar E. Hassan, Ayman A. Farghaly & Zeinab M. Hassan. (2022) Genotoxicity, DNA damage and sperm defects induced by vinblastine. Molecular Biology Reports 50:2, pages 1059-1068.
Crossref
Crossref
Eugene Cho, Hyoun Woo Kim, Da Hye Jeong, Seokmyon Lee, Deuk-Sil Oh & Jin Kim. (2022)
Evaluation of antioxidant and anticancer activities of fermented pericarp extract of
Camellia japonica
L. using
Aspergillus oryzae
in oral cancer
. Oral Biology Research 46:3, pages 111-118.
Crossref
Crossref
Adeoluwa A. Adeluola, Nana Bosomtwe, Timothy E Long & A. R. M. Ruhul Amin. (2022) Context-dependent activation of p53 target genes and induction of apoptosis by actinomycin D in aerodigestive tract cancers. Apoptosis 27:5-6, pages 342-353.
Crossref
Crossref
Eugene Cho, Jin Kim, Da Hye Jeong & Hyoun Woo Kim. (2021) Anticancer properties of dried-pericarp water extracts of Camellia japonica L. fermented with Aspergillus oryzae through regulation of IGFBP-2/mTOR pathway. Scientific Reports 11:1.
Crossref
Crossref
Abolfazl Akbari, Meghdad Sedaghat, Javad Heshmati, Seidamir Pasha Tabaeian, Sadegh Dehghani, Ana Beatriz Pizarro, Zahra Rostami & Shahram Agah. (2021) Molecular mechanisms underlying curcumin-mediated microRNA regulation in carcinogenesis; Focused on gastrointestinal cancers. Biomedicine & Pharmacotherapy 141, pages 111849.
Crossref
Crossref
Andrea Lees, Tamas Sessler & Simon McDade. (2021) Dying to Survive—The p53 Paradox. Cancers 13:13, pages 3257.
Crossref
Crossref
Bavani Gunasegaran, Paul M. Neilsen & Scott D. Smid. (2020) P53 activation suppresses irinotecan metabolite SN-38-induced cell damage in non-malignant but not malignant epithelial colonic cells. Toxicology in Vitro 67, pages 104908.
Crossref
Crossref
M. N. Yurova. (2020) The Use of Geroprotective Agents (mTOR Inhibitors) in the Treatment of Cancer Patients. Advances in Gerontology 10:3, pages 287-291.
Crossref
Crossref
Benjamin B. Mull, J. Andrew Livingston, Nalini Patel, Tuyen Bui, Kelly K. Hunt & Khandan Keyomarsi. (2020) Specific, reversible G1 arrest by UCN-01 in vivo provides cytostatic protection of normal cells against cytotoxic chemotherapy in breast cancer. British Journal of Cancer 122:6, pages 812-822.
Crossref
Crossref
Jessica J. Miller, Anaïs Blanchet, Christophe Orvain, Lucienne Nouchikian, Yasmin Reviriot, Ryan M. Clarke, Diego Martelino, Derek Wilson, Christian Gaiddon & Tim Storr. (2019) Bifunctional ligand design for modulating mutant p53 aggregation in cancer. Chemical Science 10:46, pages 10802-10814.
Crossref
Crossref
Rabia Hameed, Afsar Khan, Sehroon Khan & Shagufta Perveen. (2019) Computational Approaches Towards Kinases as Attractive Targets for Anticancer Drug Discovery and Development. Anti-Cancer Agents in Medicinal Chemistry 19:5, pages 592-598.
Crossref
Crossref
Hannah E. Walters & Lynne S. Cox. (2019) Generation of a novel model of primary human cell senescence through Tenovin-6 mediated inhibition of sirtuins. Biogerontology 20:3, pages 303-319.
Crossref
Crossref
Karen A. Urtishak, Li-San Wang, Biljana Culjkovic-Kraljacic, James W. Davenport, Patrizia Porazzi, Tiffaney L. Vincent, David T. Teachey, Sarah K. Tasian, Jonni S. Moore, Alix E. Seif, Shenghao Jin, Jeffrey S. Barrett, Blaine W. Robinson, I-Ming L. Chen, Richard C. Harvey, Martin P. Carroll, Andrew J. Carroll, Nyla A. Heerema, Meenakshi Devidas, ZoAnn E. Dreyer, Joanne M. Hilden, Stephen P. Hunger, Cheryl L. Willman, Katherine L. B. Borden & Carolyn A. Felix. (2018) Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia. Oncogene 38:13, pages 2241-2262.
Crossref
Crossref
Marcus J. G. W. Ladds, Andrés Pastor-Fernández, Gergana Popova, Ingeborg M. M. van Leeuwen, Kai Er Eng, Catherine J. Drummond, Lars Johansson, Richard Svensson, Nicholas J. Westwood, Anna R. McCarthy, Fredrik Tholander, Mihaela Popa, David P. Lane, Emmet McCormack, Gerald M. McInerney, Ravi Bhatia & Sonia Laín. (2018) Autophagic flux blockage by accumulation of weakly basic tenovins leads to elimination of B-Raf mutant tumour cells that survive vemurafenib. PLOS ONE 13:4, pages e0195956.
Crossref
Crossref
Russell T. Sapio, Anastasiya N. Nezdyur, Matthew Krevetski, Leonid Anikin, Vincent J. Manna, Natalie Minkovsky & Dimitri G. Pestov. (2017) Inhibition of post-transcriptional steps in ribosome biogenesis confers cytoprotection against chemotherapeutic agents in a p53-dependent manner. Scientific Reports 7:1.
Crossref
Crossref
Lara J. Bou Malhab, Simon Descamps, Benedicte Delaval & Dimitris P. Xirodimas. (2016) The use of the NEDD8 inhibitor MLN4924 (Pevonedistat) in a cyclotherapy approach to protect wild-type p53 cells from MLN4924 induced toxicity. Scientific Reports 6:1.
Crossref
Crossref
Yizhu Li, Priyanka Saini, Anusha Sriraman & Matthias Dobbelstein. (2015) Mdm2 inhibition confers protection of p53-proficient cells from the cytotoxic effects of Wee1 inhibitors. Oncotarget 6:32, pages 32339-32352.
Crossref
Crossref
Kensuke Kojima & Michael Andreeff. 2015. Targeted Therapy in Translational Cancer Research. Targeted Therapy in Translational Cancer Research
353
359
.
Matthias Dobbelstein & Claus Storgaard Sørensen. (2015) Exploiting replicative stress to treat cancer. Nature Reviews Drug Discovery 14:6, pages 405-423.
Crossref
Crossref
Giuseppe S. Sica, Cristina Fiorani, Carmine Stolfi, Giovanni Monteleone, Eleonora Candi, Ivano Amelio, Valeria Catani, Simone Sibio, Andrea Divizia, Giorgia Tema, Edoardo Iaculli & Achille L. Gaspari. (2015) Peritoneal expression of matrilysin helps identify early post-operative recurrence of colorectal cancer. Oncotarget 6:15, pages 13402-13415.
Crossref
Crossref
Samriti Dogra, Sriram Bandi, Preeti Viswanathan & Sanjeev Gupta. (2015) Arsenic trioxide amplifies cisplatin toxicity in human tubular cells transformed by HPV-16 E6/E7 for further therapeutic directions in renal cell carcinoma. Cancer Letters 356:2, pages 953-961.
Crossref
Crossref
Luciana E. Giono, M. Fátima Ladelfa & Martín Monte. 2015. Stress Response Pathways in Cancer. Stress Response Pathways in Cancer
51
73
.
Emmanouil Athanasakis, Elisabetta Melloni, Gian Matteo Rigolin, Chiara Agnoletto, Rebecca Voltan, Diego Vozzi, Elisa Piscianz, Ludovica Segat, Simeone Dal Monego, Antonio Cuneo, Paola Secchiero & Giorgio Zauli. (2014) The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias. Oncotarget 5:24, pages 12635-12645.
Crossref
Crossref
Ingvild Haaland, Jill A Opsahl, Frode S Berven, Håkon Reikvam, Hanne K Fredly, Ragnhild Haugse, Bernd Thiede, Emmet McCormack, Sonia Lain, Øystein Bruserud & Bjørn Tore Gjertsen. (2014) Molecular mechanisms of nutlin-3 involve acetylation of p53, histones and heat shock proteins in acute myeloid leukemia. Molecular Cancer 13:1.
Crossref
Crossref
Yalda Khosravi, Yakhya Dieye, Mun Fai Loke, Khean Lee Goh & Jamuna Vadivelu. (2014) Streptococcus mitis Induces Conversion of Helicobacter pylori to Coccoid Cells during Co-Culture In Vitro. PLoS ONE 9:11, pages e112214.
Crossref
Crossref
Eng-Yen Huang, Feng-Sheng Wang, Yu-Min Chen, Yi-Fan Chen, Chung-Chi Wang, I-Hui Lin, Yu-Jie Huang & Kuender D. Yang. (2014) Amifostine alleviates radiation-induced lethal small bowel damage via promotion of 14-3-3σ-mediated nuclear p53 accumulation. Oncotarget 5:20, pages 9756-9769.
Crossref
Crossref
Masashi Idogawa, Tomoko Ohashi, Jun Sugisaka, Yasushi Sasaki, Hiromu Suzuki & Takashi Tokino. (2014) Array-based genome-wide RNAi screening to identify shRNAs that enhance p53-related apoptosis in human cancer cells. Oncotarget 5:17, pages 7540-7548.
Crossref
Crossref
Chiara Agnoletto, Elisabetta Melloni, Fabio Casciano, Gian Matteo Rigolin, Erika Rimondi, Claudio Celeghini, Laura Brunelli, Antonio Cuneo, Paola Secchiero & Giorgio Zauli. (2014) Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3. Oncotarget 5:12, pages 4347-4360.
Crossref
Crossref
Rabih Said, Yang Ye, David S. Hong, Filip Janku, Siqing Fu, Aung Naing, Jennifer J. Wheler, Razelle Kurzrock, Christoforos Thomas, Gary A. Palmer, Kenneth R. Hess, Kenneth Aldape & Apostolia M. Tsimberidou. (2014) Characteristics and survival of patients with advanced cancer and p53 mutations. Oncotarget 5:11, pages 3871-3879.
Crossref
Crossref
Rebecca Voltan, Paola Secchiero, Federica Corallini & Giorgio Zauli. (2014) Selective induction of TP53I3/p53-inducible gene 3 (PIG3) in myeloid leukemic cells, but not in normal cells, by Nutlin-3. Molecular Carcinogenesis 53:6, pages 498-504.
Crossref
Crossref
Lisa Lange, Sarah Keppner-Witter, Juline Grigat & Birgit Spänkuch. (2014) Combinatorial inhibition of Plk1 and PKCβ in cancer cells with different p53 status. Oncotarget 5:8, pages 2263-2275.
Crossref
Crossref
Kian Hoe Khoo, Chandra S. Verma & David P. Lane. (2014) Drugging the p53 pathway: understanding the route to clinical efficacy. Nature Reviews Drug Discovery 13:3, pages 217-236.
Crossref
Crossref
Chih-Shou Chen, Dong-Ru Ho, Fei-Yun Chen, Chang-Rong Chen, Yu-De Ke & Jyan-Gwo Joseph Su. (2014) AKT mediates actinomycin D-induced p53 expression. Oncotarget 5:3, pages 693-703.
Crossref
Crossref
B Rao, S Lain & A M Thompson. (2013) p53-Based cyclotherapy: exploiting the ‘guardian of the genome’ to protect normal cells from cytotoxic therapy. British Journal of Cancer 109:12, pages 2954-2958.
Crossref
Crossref
M. Janaki Ramaiah, Sreerangam N.C.V.L. Pushpavalli, A. Lavanya, Kaustav Bhadra, V. Haritha, Nibedita Patel, Jaki R. Tamboli, Ahmed Kamal, Utpal Bhadra & Manika Pal-Bhadra. (2013) Novel anthranilamide-pyrazolo[1,5-a]pyrimidine conjugates modulate the expression of p53-MYCN associated micro RNAs in neuroblastoma cells and cause cell cycle arrest and apoptosis. Bioorganic & Medicinal Chemistry Letters 23:20, pages 5699-5706.
Crossref
Crossref
M C C Sachweh, C J Drummond, M Higgins, J Campbell & S Laín. (2013) Incompatible effects of p53 and HDAC inhibition on p21 expression and cell cycle progression. Cell Death & Disease 4:3, pages e533-e533.
Crossref
Crossref
Mikhail V. Blagosklonny. (2012) Common drugs and treatments for cancer and age-related diseases: revitalizing answers to NCI's provocative questions. Oncotarget 3:12, pages 1711-1724.
Crossref
Crossref
Kimberly M. Sutton, Carolyn D. Doucette & David W. Hoskin. (2012) NADPH quinone oxidoreductase 1 mediates breast cancer cell resistance to thymoquinone-induced apoptosis. Biochemical and Biophysical Research Communications 426:3, pages 421-426.
Crossref
Crossref
Mikhail V. Blagosklonny. (2012) Wt p53 impairs response to chemotherapy: make lemonade to spare normal cells. Oncotarget 3:6, pages 601-607.
Crossref
Crossref
Ingeborg M.M. van Leeuwen. (2012) Cyclotherapy: opening a therapeutic window in cancer treatment. Oncotarget 3:6, pages 596-600.
Crossref
Crossref